TRUMF : Summary for TERUMO CORP NPV - Yahoo Finance

U.S. Markets open in 3 hrs 11 mins

Terumo Corporation (TRUMF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
37.050.00 (0.00%)
At close: 10:19AM EST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close37.05
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52 Week Range
Avg. Volume50
Market Cap13.93B
PE Ratio (TTM)37.50
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Zacks Small Cap Research2 days ago

    CTSO: Poised For Strong 2017. Fresenius Deal A Win-Win-Win

    CytoSorbents (CTSO) has had a busy last couple of months leading up to the annual JP Morgan, Biotech Showcase and Medtech Showcase conferences which were held earlier this week in San Francisco and where management took some time to talk to us.  Just prior to the company’s presentation at the Biotech Showcase they announced an expanded agreement with Fresenius and preannounced expected Q4 and FY2016 product sales. Per the January 10th preannouncement, CTSO expects Q4 product sales of ~$2.6M, implying sequential and yoy growth of approximately 21% and 74%, respectively, and marking the sixth straight quarter of record product sales.  Product sales of $2.6M is also almost 16% higher than what we had forecast ($2.2M).

  • TheStreet.com21 days ago

    FTC Allows Abbott to Spin Off Units, Buy St. Jude Medical

    Abbott can now proceed with its $25 billion buy of St. Jude Medical.

  • The Wall Street Journal2 months ago

    [$$] Abbott, St. Jude Medical to Sell $1.1 Billion in Assets

    Abbott Laboratories and St. Jude said they would sell certain businesses to Terumo for about $1.1 billion as the two American companies march toward completing their merger.